CoreWeave beats Q3 revenue estimates and raises 2026 forecast

2 min read
CoreWeave beats Q3 revenue estimates and raises 2026 forecast
PrimeXBT Editorial Team
Reviewed by PrimeXBT

CoreWeave beat Wall Street's third-quarter revenue estimate and raised its 2026 forecast on Tuesday. The results come after the stock lost over 40% of its value in a month, as concerns about debt and access to capital grew.

CoreWeave reported third-quarter revenue of $3.66 billion, against $3.55 billion expected by analysts in the LSEG consensus. The company also lifted its 2026 guidance, showing that demand for AI infrastructure remains strong despite concerns of a market slowdown.

Revenue soared 168% from about $1.36 billion a year earlier. However, the company recorded a net loss of $709 million, or $1.27 per share, compared with a net loss of $110 million a year earlier.

Guidance moves above analyst estimates

Executives now see $13 billion to $13.3 billion in revenue and $1.275 billion to $1.375 billion in adjusted operating income for 2026. In August, CoreWeave had projected $12.4 billion to $13.2 billion in revenue. Analysts polled by LSEG had expected $12.86 billion in 2026 revenue.

Demand remains robust, with a $132.5 billion revenue backlog, up from $104 billion as of June. CoreWeave is also targeting $37 billion to $39 billion in full-year capital expenditures.

Debt and rising rates pressure the stock

The shares have lost over 40% of their value in the past month as investors rotate out of companies most closely tied to AI infrastructure. Rising interest rates have pushed lenders out of the market, raising concerns about ongoing access to capital. Some CoreWeave bond yields recently topped 16%, and the company owed almost $47 billion in debt at the end of the third quarter.

Reuters reported that the shares were up more than 7% in extended trading. CEO Mike Intrator addressed the financing concerns in a statement. According to Reuters: "Customer contracts come first, and investment follows," he said.

CoreWeave investors are also looking toward next week, when key customer Anthropic is scheduled to debut on the Nasdaq.

Sources: CNBC, Reuters via Investing.com

Trading involves risk.

Author

PrimeXBT
Our Editorial Team consists of leading experts with a proven record in the fields of trading, cryptocurrencies, blockchain and finance. We thoroughly research the sources of information in order to provide readers with quality content that serves edu...
Read author’s articles
Alert Triangle Risk Disclaimer
Disclaimer: Some past publications may be outdated. We recommend following our news to stay up to date with the latest information. For any questions, feel free to contact our support team via the chat below.
The content provided here is for informational purposes only. It is not intended as personal investment advice and does not constitute a solicitation or invitation to engage in any financial transactions, investments, or related activities. Past performance is not a reliable indicator of future results.
The financial products offered by the Company are complex and come with a high risk of losing money rapidly due to leverage. These products may not be suitable for all investors. Before engaging, you should consider whether you understand how these leveraged products work and whether you can afford the high risk of losing your money.
The Company does not accept clients from the Restricted Jurisdictions as indicated in our website/ T&C. Some services or products may not be available in your jurisdiction.
The applicable legal entity and its respective products and services depend on the client’s country of residence and the entity with which the client has established a contractual relationship during registration.

Today in markets

Browse Stock News

Register Now

Trading involves risk

Get started in minutes

Our clients love how fast and simple our sign-up is. It takes just a few minutes to get started!

Get Started Get Started
Get started in minutes

Need Help?

Risk Warning:
Trading in leveraged products carries a high level of risk and may not be suitable for all investors.